The use of biomarkers that show an association with the development of cardiovascular di- sease needs a careful evaluation in regard to the quality of evidence that establishes their relationship. Although observational studies have been paramount to establish the importance of the traditional risk factors, we can only screen and intervene on biomarkers when there is demonstrated benefit in well-designed randomized clinical trials.
|Number of pages||4|
|Journal||Archivos de Cardiologia de Mexico|
|State||Published - Apr 2011|
- Observational studies
- Randomized controlled trials
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine